COVID-19
As industry leaders in infection prevention, our mission is to ensure that our customers are protected against the threat of emerging disease outbreaks in all of the markets we serve. Recent testing has demonstrated that Rejuvenate is effective against SARS-CoV-2, the virus that causes COVID-19. This testing provides confidence that the product will be highly effective in preventing the spread of COVID-19 when used according to label instructions. In choosing Rejuvenate as your daily disinfectant, we want to ensure you have the confidence that your clients and team are covered in the event of an outbreak as well as for everyday use.
August 19, 2022
To Whom it May Concern, In cases of emerging viral pathogens such as Monkeypox Virus, when there is no test that can be conducted to validate the efficacy of a disinfectant, the US Environmental Protection Agency utilizes their Emerging Viral Pathogens Policy to determine the expected efficacy of a disinfectant against an emerging virus. In the case of an enveloped virus such as Monkeypox Virus, the following criteria are used to determine efficacy of a disinfectant upon enactment of the […]
September 16, 2021
To Whom It May Concern, Virox® is pleased to announce that RejuvenateTM One-Step Disinfectant Wipes (Rejuvenate) has received an EPA-approved label claim for use against SARS-CoV-2, the virus that causes COVID-19. The product has been validated by independent testing and proven efficacious against SARS-CoV-2, following a contact time of one minute. Rejuvenate also appears on the EPA’s List N, which identifies disinfectants that are appropriate for use against SARS-CoV-2, the virus that causes COVID-19 – this can be found by […]
September 16, 2021
To Whom It May Concern, Virox® Technologies Inc. is pleased to announce that Rejuvenate Ready-to-Use One-Step Disinfectant (Rejuvenate) has received an EPA-approved label claim for use against SARS-CoV-2, the virus that causes COVID-19. The product has been validated by independent testing and proven efficacious against SARS-CoV-2, following a contact time of one minute. Rejuvenate also appears on the EPA’s List N, which identifies disinfectants that are appropriate for use against SARS-CoV-2, the virus that causes COVID-19 – this can be […]
July 8, 2021
Virox™ is pleased to announce that several of our Accelerated Hydrogen Peroxide® (AHP®) wipe formulations have been validated by independent testing and proven efficacious against SARS-CoV- 2, the virus that causes COVID-19 disease. As industry leaders in infection prevention, our mission is to ensure our customers are protected against the threat of emerging disease outbreaks in all of the markets we serve. As COVID-19 began to spread worldwide, public health officials issued recommendations to practice physical distancing, regular hand hygiene and […]
July 8, 2021
Trusted in times of crisis, Rejuvenate™, formulated with Accelerated Hydrogen Peroxide® is approved for use against SARS-CoV-2, the virus that causes COVID-19 when used in accordance with the directions for use against Poliovirus type 1. For Rejuvenate™ Concentrate use a 1:16 dilution and contact time 5 minutes and a contact time of 1 minute for Rejuvenate™ RTU and Wipes. For further information, please review our formal press release below. CLICK HERE TO VIEW PDF >
July 8, 2021
Virox Technologies Inc. continues to closely monitor the COVID-19 pandemic (SARS-CoV-2) and its impact on both our end users and distribution partners. Our number one priority is to help ensure the health and safety of everyone affected by the current outbreak. As time is of the essence when implementing a standard infection preven- tion protocol during a pandemic, we have more than doubled production of our Accelerated Hydrogen Peroxide® disinfectants to ensure uninterrupted supply at this critical time. CLICK HERE […]